1.	Phase III Randomized Comparison of VMCP/VBAP (VCR/L-PAM/CTX/PRED Alternating with VCR/BCNU/ADR/PRED) vs VAD (VCR/ADR/DM) for Induction and IFN vs No Therapy for Maintenance in Patients with Multiple Myeloma Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: SWOG-8624
2.	Phase I/II Study of Intrahepatic DOX and Verapamil in Patients with Hepatic Metastases (Summary Last Modified 11/92) Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Protocol IDs: MSKCC-91019, NCI-V91-0101
3.	Phase II Pilot Chemotherapy with ADR/Verapamil for Refractory Ovarian Cancer in Adults Phase: Phase II Type: Treatment Status: Completed Age: 20 to 70 Sponsor: NCI Protocol IDs: NCI-84-C-21, NCI-MB-188, NCI-T84-0252N, T84-0252
4.	Phase II Pilot Study of Combination Chemotherapy with ADR/VCR plus Verapamil in Patients with Small Cell Lung Cancer Refractory to Chemotherapy with ADR/VCR Phase: Phase II Type: Treatment Status: Closed Age: over 18 Sponsor: NCI Protocol IDs: EST-PE-584, EST-P-E584
5.	Phase II Randomized Pilot Study of VAD (VCR/ADR/DM) vs VAD/V (VAD/Verapamil) in Patients with Stage I/II/III Multiple Myeloma Who Have Failed Prior Combination Chemotherapy (Summary Last Modified 06/89) Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: SWOG-8900
6.	Phase II Trial of CVAD (CTX/VCR/ADR/DM) plus Verapamil in Patients with Drug-Refractory Intermediate-Grade and Selected High-Grade non-Hodgkin's Lymphomas (Summary Last Modified 10/89) Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: SWOG-8907
7.	Phase II Study of CVAD (CTX/VCR/DOX/DM) with Verapamil/Quinine in Patients with Intermediate- and High-Grade non-Hodgkin's Lymphoma Phase: Phase II Type: Treatment Status: Closed Age: 15 and over Sponsor: NCI Protocol IDs: SWOG-9125
8.	Phase II Study of DOX/VBL Combined with P-Glycoprotein Inhibitors (Trifluoperazine and Verapamil) in Patients with Advanced Renal Cell Carcinoma (Summary Last Modified 04/93) Phase: Phase II Type: Treatment Status: Closed Age: adult Sponsor: NCI Protocol IDs: SWOG-9104
9.	Combination of Hydroxyurea and Verapamil for Refractory Meningiomas Phase: Phase II Type: Treatment Status: Temporarily closed Age: Over 18 Sponsor: Other Protocol IDs: HCI25089, NCT00706810
10.	Phase I Clinical and Pharmacologic Trial of Concurrent Intravenous Verapamil and Adriamycin Phase: Phase I Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: UMCC-8319, NCI-T83-1226W, T83-1226
11.	Phase I Study of Vinblastine and Verapamil by Concurrent Intravenous Infusion Phase: Phase I Type: Treatment Status: Closed Age: 16 and over Sponsor: Protocol IDs: WCCC-CO-8133